Glioma is a broad category of brain and spinal cord tumors that come from glial cells brain cells that support nerve cells.The symptoms, prognosis, and treatment of a glioma depend on the person’s age, the exact type of tumor, and the location of the tumor within the brain.
In 2018, the global Adult Malignant Glioma Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Adult Malignant Glioma Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adult Malignant Glioma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Merck
Hoffmann-La Roche
Arbor Pharmaceuticals
Pfizer
AbbVie
Amgen
Bristol-Myers Squibb
Sun Pharmaceutical
Teva Pharmaceutical
Novocure
Eli Lilly
AstraZeneca
Novartis AG

Market segment by Type, the product can be split into

Glioblastoma Multiforme
Anaplastic Astrocytoma
Anaplastic Oligodendroglioma
Other

Market segment by Application, split into

Hospitals
Specialty Clinics
Cancer and Radiation Therapy Centers
Others

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Adult Malignant Glioma Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Adult Malignant Glioma Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Adult Malignant Glioma Therapeutics are as follows:
History Year: 2014-2018

Base Year:

2018

Estimated Year:

2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.